Gene · 2168
Papers3,436
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
961 to 980 of 3,436
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Aqueous Level of ANGPTL4 Correlates with the OCTA Metrics of Diabetic Macular Edema in NPDR. | J Diabetes Res | 2022 | 35097131 | PubTator, text mining | PubMed |
| Advances in Understanding the Role of Aloe Emodin and Targeted Drug Delivery Systems in Cancer. | Oxid Med Cell Longev | 2022 | 35087619 | PubTator, text mining | PubMed |
| Combined serum free light chain predicts prognosis in acute kidney injury following cardiovascular surgery. | Ren Fail | 2022 | 35086423 | PubTator, text mining | PubMed |
| Roles of necroptosis in alcoholic liver disease and hepatic pathogenesis. | Cell Prolif | 2022 | 35083817 | PubTator, text mining | PubMed |
| Topiroxostat versus allopurinol in patients with chronic heart failure complicated by hyperuricemia: A prospective, randomized, open-label, blinded-end-point clinical trial. | PLoS One | 2022 | 35077456 | PubTator, text mining | PubMed |
| Role of Metabolic Reprogramming of Long non-coding RNA in Clear Cell Renal Cell Carcinoma. | J Cancer | 2022 | 35069912 | PubTator, text mining | PubMed |
| Serum chromogranin A correlated with albuminuria in diabetic patients and is associated with early diabetic nephropathy. | BMC Nephrol | 2022 | 35062888 | PubTator, text mining | PubMed |
| Identifying Candidate Protein Markers of Acute Kidney Injury in Acute Decompensated Heart Failure. | Int J Mol Sci | 2022 | 35055195 | PubTator, text mining | PubMed |
| Biomarkers in EndoVascular Aneurysm Repair (EVAR) and Abdominal Aortic Aneurysm: Pathophysiology and Clinical Implications. | Diagnostics (Basel) | 2022 | 35054350 | PubTator, text mining | PubMed |
| The Pathophysiology and the Management of Radiocontrast-Induced Nephropathy. | Diagnostics (Basel) | 2022 | 35054347 | PubTator, text mining | PubMed |
| New Insights from Metabolomics in Pediatric Renal Diseases. | Children (Basel) | 2022 | 35053744 | PubTator, text mining | PubMed |
| Unveiling the Role of the Fatty Acid Binding Protein 4 in the Metabolic-Associated Fatty Liver Disease. | Biomedicines | 2022 | 35052876 | PubTator, text mining | PubMed |
| Detailed Molecular Mechanisms Involved in Drug-Induced Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: An Update. | Biomedicines | 2022 | 35052872 | PubTator, text mining | PubMed |
| Proteomic profiling identifies novel diagnostic biomarkers and molecular subtypes for mucinous tubular and spindle cell carcinoma of the kidney. | J Pathol | 2022 | 35043389 | PubTator, text mining | PubMed |
| Prediction model of acute kidney injury induced by cisplatin in older adults using a machine learning algorithm. | PLoS One | 2022 | 35041690 | PubTator, text mining | PubMed |
| Metformin use in patients hospitalized with COVID-19: lower inflammation, oxidative stress, and thrombotic risk markers and better clinical outcomes. | J Thromb Thrombolysis | 2022 | 35041121 | PubTator, text mining | PubMed |
| Biomarkers of acute kidney injury after pediatric cardiac surgery: a meta-analysis of diagnostic test accuracy. | Eur J Pediatr | 2022 | 35039910 | PubTator, text mining | PubMed |
| Clinical Utility of a Biomarker to Detect Contrast-Induced Acute Kidney Injury during Percutaneous Cardiovascular Procedures. | Cardiorenal Med | 2022 | 35034025 | PubTator, text mining | PubMed |
| Association of metabolic syndrome traits with urinary biomarkers in Japanese adults. | Diabetol Metab Syndr | 2022 | 35033174 | PubTator, text mining | PubMed |
| Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium. | Nat Rev Cardiol | 2022 | 35027697 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2168/papers?page=49